This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Newsoara Biopharma Co., Ltd.. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Yuannian Li: Innovator in Antibody Development
Introduction
Yuannian Li is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of biotechnology, particularly in the development of neutralizing antibodies against SARS-CoV-2. With a total of 2 patents, his work is crucial in the ongoing fight against viral infections.
Latest Patents
Li's latest patents include innovative solutions for combating SARS-CoV-2. The first patent focuses on novel neutralizing antibodies against SARS-CoV-2, providing pharmaceutical compositions and kits that utilize these antibodies. The second patent involves recombinant expression vectors that express these neutralizing antibodies or their antigen binding fragments, along with associated pharmaceutical compositions and kits.
Career Highlights
Yuannian Li is currently associated with Newsoara Biopharma Co., Ltd., where he continues to advance research in antibody development. His work is instrumental in creating effective therapeutic options for viral infections, showcasing his dedication to improving public health.
Collaborations
Li collaborates with various professionals in the field, including his coworker Wenyi Wang, to enhance the scope and impact of his research.
Conclusion
Yuannian Li's innovative work in the development of neutralizing antibodies against SARS-CoV-2 positions him as a key figure in biotechnology. His contributions are vital for advancing therapeutic solutions in the fight against viral diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile